A A A

Glossary


Pathology and staging of prostate cancer

Pathology refers to the careful examination of tissue under a microscope in order to find out whether it's cancerous or non-cancerous and to determine the type of tumour it is. Different types of tumours can affect the prostate gland.

Benign conditions

Benign conditions that cause non-cancerous enlargement or swelling of the prostate do not spread to other parts of the body and are not usually life-threatening:

  • benign prostatic hyperplasia (BPH)
  • prostatitis

Precancerous conditions

Precancerous conditions have the potential to develop into cancer:

  • prostatic intraepithelial neoplasia (PIN)
  • proliferative inflammatory atrophy (PIA)
  • atypical small acinar proliferation (ASAP)

Malignant tumours

Malignant tumours are cancerous growths that have the potential to metastasize (spread to other parts of the body):

  • adenocarcinoma – accounts for 95% of malignant tumours
  • rare malignant tumours
    • transitional cell carcinoma
    • sarcoma
    • small cell (neuroendocrine) carcinoma
    • ductal carcinoma
    • mucinous carcinoma
    • endometrioid or large duct carcinoma
    • primary lymphoma of the prostate

 

Once the type of tumour has been diagnosed, the doctor will also consider:

  • the grade of the tumour (how abnormal the cancer cells look and behave)
  • the stage of the cancer, including if it has spread (metastasized) and where it has spread
  • prognostic factors (special characteristics that might influence the course of the disease)
  • survival statistics for the particular type and stage of cancer

 

All of this information helps the doctor make a treatment plan.

 

See a list of questions to ask your doctor about pathology and staging.

 

References

We’re here to help. Tell us what you’re looking for, and an information specialist will email or call you.

500

Name:

Email address:

Phone number:

Postal code:

We can give information about cancer care and support services in Canada only. To find a cancer organization in your country, visit Union for International Cancer Control or International Cancer Information Service Group.